The purpose of this notice is to extend the expiration date of PA-24-247 PHS 2024-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed) by one receipt date. PA-24-247 will now expire on September 6, 2025.

Due to the extension, the following dates will be added:

Standard application due date : September 5, 2025
Scientific Merit Review: November 2025
Advisory Council: January 2026

The following sections of the FOA have been changed:

Part 1. Overview Information, Key Dates

Currently reads:

Application Due DatesReview and Award CyclesNewRenewal / Resubmission / Revision (as allowed)AIDS – New/Renewal/Resubmission/Revision, as allowedScientific Merit ReviewAdvisory Council ReviewEarliest Start DateSeptember 05, 2024 *September 05,

Click this link to continue reading the article on the source website.

The purpose of this notice is to extend the expiration date of PA-24-246 PHS 2024-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required) by one receipt date. PA-24-246 will now expire on September 6, 2025.

Due to the extension, the following dates will be added:

Standard application due date : September 5, 2025
Scientific Merit Review: November 2025
Advisory Council: January 2026

The following sections of the FOA have been changed:

Part 1. Overview Information, Key Dates

Currently reads:

Application Due DatesReview and Award CyclesNewRenewal / Resubmission / Revision (as allowed)AIDS – New/Renewal/Resubmission/Revision, as allowedScientific Merit ReviewAdvisory Council ReviewEarliest Start DateSeptember 05, 2024

Click this link to continue reading the article on the source website.

The purpose of this notice is to extend the expiration date of PA-24-245 PHS 2024-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed) by one receipt date. PA-24-245 will now expire on September 6, 2025.

Due to the extension, the following dates will be added:

Standard application due date : September 5, 2025
Scientific Merit Review: November 2025
Advisory Council: January 2026

The following sections of the NOFO have been changed:

Part 1. Overview Information, Key Dates

Currently reads:

Application Due DatesReview and Award CyclesNewRenewal / Resubmission / Revision (as allowed)AIDS – New/Renewal/Resubmission/Revision, as allowedScientific Merit ReviewAdvisory Council ReviewEarliest

Click this link to continue reading the article on the source website.

Institutional Biosafety Committees (IBCs) serve as a critical linchpin in ensuring the safe and responsible conduct of research. Since the issuance of the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules (NIH Guidelines) in 1976, IBCs have expanded in number to the thousands and have voluntarily expanded their roles to encompass new research approaches as they arise.

IBCs continue to serve as a pillar of biosafety oversight and are essential in building trust on behalf of the biomedical research enterprise. Under the NIH Guidelines, this expectation is a mandate and as such, NIH is reinforcing its commitment to working with IBCs to ensure transparency in biosafety oversight by updating its implementation expectations to protect the safety of all

Click this link to continue reading the article on the source website.